Digital Digital measures for value-based healthcare: Current perspec... In the ever-evolving landscape of healthcare, the concept of value-based care (VBC) has gained substantial momentum in recent years.
Patients No return to the status quo: Why now is the time for value-b... Value-based, person-centred healthcare is the key to system resilience – and now is the time to make it happen.
Views & Analysis Value-based healthcare: Pandemic learnings and future musing... In the second part of our series from the 'Patient Experience: Empathy and Innovation' Digital Summit, we look at what COVID-19 can teach us about designing truly value-based healthcare.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends